sirolimus
Phase 2- Indications
- Coronary artery disease, Peripheral artery disease, In-stent restenosis
Company intelligence / Profile preview
Orchestra BioMed
New Hope, Pennsylvania, United Statesorchestrabiomed.com ↗
- Ownership
- Public · OBIO
- Employees
- ~63
- Development stage
- Phase 2
01
Overview
Orchestra BioMed has two late-stage flagship technologies. BackBeat CNT™/AVIM therapy for hypertension has received FDA Breakthrough Device Designation and continues pivotal study execution in collaboration with Medtronic. Virtue SAB for atherosclerotic artery disease has also received multiple FDA Breakthrough Device Designations and an IDE approval to launch a U.S. pivotal trial in partnership with Terumo. Recent data show favorable impact on cardiac function for AVIM therapy; neither product is yet commercially approved.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceDrug/device combination product
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Medtronic (strategic collaboration on AVIM/BackBeat CNT for hypertension)Terumo Corporation (global strategic partnership on Virtue SAB)
04
Financials
- Market cap
- $337.8M
- Total revenue
- $33.5M
- Enterprise value
- $298.6M
Beyond the preview
Go deeper on Orchestra BioMed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Orchestra BioMed.